Overview

Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose Tolerance

Status:
Withdrawn

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

Summary

LIM-0705 will gain results on the effects of LIM-0705 on Male Subjects with Impaired Glucose Tolerance

Phase:

Phase 1

Details

Lead Sponsor:

Limerick BioPharma